Agranulocytosis classification

Revision as of 15:55, 21 September 2012 by Prashanthsaddala (talk | contribs)
Jump to navigation Jump to search

Agranulocytosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Agranulocytosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Agranulocytosis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Agranulocytosis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Agranulocytosis classification

CDC on Agranulocytosis classification

Agranulocytosis classification in the news

Blogs on Agranulocytosis classification

Directions to Hospitals Treating Agranulocytosis

Risk calculators and risk factors for Agranulocytosis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Classification

The term "agranulocytosis" derives from the Greek: a, meaning without; granulocyte, a particular kind of cell; osis, meaning condition [esp. disorder]. Consequently, agranulocytosis is sometimes described as "no granulocytes", but a total absence is not required for diagnosis. However, "-osis" is commonly used in blood disorders to imply cell proliferation (such as in "leukocytosis"), while "-penia" to imply reduced cell numbers (as in "leukopenia"); for these reasons granulopenia is a more etymologically consistent term and as such should be preferred compared to "agranulocytosis" (which can be misinterpreted as "agranulocyt-osis", meaning proliferation of agranulocytes (i.e. lymphocytes and monocytes). Despite this, "agranulocytosis" remains the most widely used term for the condition.

The terms agranulocytosis, granulocytopenia and neutropenia are sometimes used interchangeably. Agranulocytosis implies a more severe deficiency than granulocytopenia. Neutropenia indicates a deficiency of neutrophils (the most common granulocyte cell) only.

To be precise, neutropenia is the term normally used to describe absolute neutrophil counts (ANC) of less than 500 cells per microlitre, whereas agranulocytosis is reserved for cases with ANC of less than 100 cells per microlitre.

The following terms can be used to specify the type of granulocyte referenced:

References


Template:WikiDoc Sources